Intestinal protozoan infections in the immunocompromised host

Current Opinion in Infectious Diseases

Volumn 26, Issue 4, 2013, Pages 295-301

  Marcos, Luis A ^a   Gotuzzo, Eduardo ^a  

^a INSTITUTO DE MEDICINA TROPICAL ALEXANDER VON HUMBOLDT   (Peru)

Author keywords

HIV; immunocompromised; intestinal parasites; protozoa; transplant

Indexed keywords

ALBENDAZOLE; COTRIMOXAZOLE; CP20 PROTEIN; FUMAGILLIN; FURAZOLIDONE; ITRACONAZOLE; METRONIDAZOLE; NITAZOXANIDE; PAROMOMYCIN; PROTOZOAL PROTEIN; RIBOSOME RNA; TINIDAZOLE; UNCLASSIFIED DRUG;

ADAPTIVE IMMUNITY; ANTIMICROBIAL THERAPY; BLASTOCYSTOSIS; BRAZIL; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM HOMINIS; CRYPTOSPORIDIUM PARVUM; CYCLOSPORA CAYETANENSIS; CYCLOSPORIASIS; ETHIOPIA; EYE INFECTION; HIGH RISK PATIENT; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMORAL IMMUNITY; IMMUNE EVASION; IMMUNOCOMPROMISED PATIENT; INDIA; INFECTION RATE; INFECTION RISK; INFECTIOUS DIARRHEA; INNATE IMMUNITY; INTESTINE PARASITE; ISOSPORA BELLI; ISOSPORIASIS; MALAYSIA; MICROSPORIDIOSIS; MULTIPLEX POLYMERASE CHAIN REACTION; NONHUMAN; PARASITE PREVALENCE; PATHOGENESIS; PERU; PROTOZOAL INFECTION; REVIEW; SCLEROSING CHOLANGITIS; THAILAND;

EID: 84879889779     PISSN: 09517375     EISSN: 14736527     Source Type: Journal    
DOI: 10.1097/QCO.0b013e3283630be3     Document Type: Review

References (59)

1. Baldursson S, Karanis P. Waterborne transmission of protozoan parasites: review of worldwide outbreaks - an update 2004-2010. Water Res 2011; 45:6603-6614.
2. Stark D, Barratt JL, van Hal S, et al. Clinical significance of enteric protozoa in the immunosuppressed human population. Clin Microbiol Rev 2009; 22:634-650.
3. Freedman DO, Weld LH, Kozarsky PE, et al. Spectrum of disease and relation to place of exposure among ill returned travelers. N Engl J Med 2006; 354:119-130. (Pubitemid 43076709)
4. Lopez-Velez R, Turrientes MC, Garron C, et al. Microsporidiosis in travelers with diarrhea from the tropics. J Travel Med 1999; 6:223-227.
5. Kotton CN. Transplant tourism and donor-derived parasitic infections. Transplant Proc 2011; 43:2448-2449.
6. Barsoum RS. Parasitic infections in transplant recipients. Nat Clin Pract Nephrol 2006; 2:490-503. (Pubitemid 44325961)
7. Maizels RM. Parasite immunomodulation and polymorphisms of the immune system. J Biol 2009; 8:62.
8. Sibley LD. Invasion and intracellular survival by protozoan parasites. Immunol Rev 2011; 240:72-91.
9. Schmid-Hempel P. Parasite immune evasion: a momentous molecular war. Trends Ecol Evol 2008; 23:318-326. (Pubitemid 351694382)
10. Velavan T, Ojurongbe O. Regulatory T cells and parasites. J Biomed Biotechnol 2011; 2011:520940. doi:10.1155/2011/520940.
11. Kothavade RJ. Challenges in understanding the immunopathogenesis of Cryptosporidium infections in humans. Eur J Clin Microbiol Infect Dis 2011; 30:1461-1472.
12. Xiao D, Yin C, Zhang Q, et al. Selection and identification of a new adhesion protein of Cryptosporidium parvum from a cDNA library by ribosome display. Exp Parasitol 2011; 129:183-189.
13. Alemu A, Shiferaw Y, Getnet G, et al. Opportunistic and other intestinal parasites among HIV/AIDS patients attending Gambi higher clinic in Bahir Dar city, North West Ethiopia. Asian Pac J Trop Med 2011; 4:661-665.
14. Viriyavejakul P, Nintasen R, Punsawad C, et al. High prevalence of Microsporidium infection in HIV-infected patients. Southeast Asian J Trop Med Public Health 2009; 40:223-228.
15. Tuli L, Gulati AK, Sundar S, et al. Correlation between CD4 counts of HIV patients and enteric protozoan in different seasons: an experience of a tertiary care hospital in Varanasi (India). BMC Gastroenterol 2008; 8:36.
16. Rodríguez Ferrero ML, Muñoz P, Valerio M, et al. Cryptosporidium parvum infection in a kidney transplant recipient. Nefrologia 2010; 30:476-477.
17. Sebastián E, Martín J, McDonald GB, et al. Cryptosporidium parvum infection vs GVHD after hematopoietic SCT: diagnosis by PCR with resolution of symptoms. Bone Marrow Transplant 2011; 46:612-614.
18. Arslan H, Inci EK, Azap OK, et al. Etiologic agents of diarrhea in solid organ recipients. Transpl Infect Dis 2007; 9:270-275. (Pubitemid 350064166)
19. Legrand F, Grenouillet F, Larosa F, et al. Diagnosis and treatment of digestive cryptosporidiosis in allogeneic haematopoietic stemcell transplant recipients: a prospective single centre study. Bone Marrow Transplant 2011; 46:858-862.
20. Wolska-Kusnierz B, Bajer A, Caccio S, et al. Cryptosporidium infection in patients with primary immunodeficiencies. J Pediatr Gastroenterol Nutr 2007; 45:458-464. (Pubitemid 350307165)
21. Denkinger CM, Harigopal P, Ruiz P, et al. Cryptosporidiumparvum- associated sclerosing cholangitis in a liver transplant patient. Transpl Infect Dis 2008; 10:133-136. (Pubitemid 351393078)
22. Amadi B, Mwiya M, Sianongo S, et al. High dose prolonged treatment with nitazoxanide is not effective for cryptosporidiosis in HIV positive Zambian children: a randomised controlled trial. BMC Infect Dis 2009; 9:195.
23. Abubakar I, Aliyu SH, Arumugam C, et al. Prevention and treatment of cryptosporidiosis in immunocompromised patients. Cochrane Database Syst Rev 2007; 1:CD004932.
24. Kaplan JE, Benson C, Holmes KH, et al. Guidelines for prevention and treatment of opportunistic infections in HIV-infected adults and adolescents: recommendations from CDC, the National Institutes of Health, and the HIV Medicine Association of the Infectious Diseases Society of America. MMWR Recomm Rep 2009; 58:1-20.
25. Ortega YR, Sanchez R. Update on Cyclospora cayetanensis, a food-borne and waterborne parasite. Clin Microbiol Rev 2010; 23:218-234.
26. Hall RL, Jones JL, Herwaldt BL. Surveillance for laboratory-confirmed sporadic cases of cyclosporiasis: United States, 1997-2008. MMWR Surveill Summ 2011; 60:1-11.
27. Kulkarni SV, Kairon R, Sane SS, et al. Opportunistic parasitic infections in HIV/AIDS patients presenting with diarrhoea by the level of immunosuppression. Indian J Med Res 2009; 130:63-66.
28. Lee SH, Joung M, Yoon S, et al. Multiplex PCR detection of waterborne intestinal protozoa: Microsporidia, Cyclospora, and Cryptosporidium. Korean J Parasitol 2010; 48:297-301.
29. Taniuchi M, Verweij JJ, Sethabutr O, et al. Multiplex polymerase chain reaction method to detect Cyclospora, Cystoisospora, and Microsporidia in stool samples. Diagn Microbiol Infect Dis 2011; 71:386-390.
30. Mundaca CC, Torres-Slimming PA, Araujo-Castillo RV, et al. Use of PCR to improve diagnostic yield in an outbreak of cyclosporiasis in Lima, Peru. Trans R Soc Trop Med Hyg 2008; 102:712-717.
31. Goldberg E, Bishara J. Contemporary unconventional clinical use of cotrimoxazole. Clin Microbiol Infect 2012; 18:8-17.
32. García C, Rodríguez E, Do N, et al. Intestinal parasitosis in patients with HIVAIDS. Rev Gastroenterol Peru 2006; 26:21-24.
33. Asma I, Johari S, Sim BL, et al. How common is intestinal parasitism in HIVinfected patients in Malaysia? Trop Biomed 2011; 28:400-410.
34. Cardoso LV, Galisteu KJ, Schiesari Júnior A, et al. Enteric parasites in HIV-1/AIDS-infected patients from a Northwestern Sao Paulo reference unit in the highly active antiretroviral therapy era. Rev Soc Bras Med Trop 2011; 44:665-669.
35. Aksoy U, Tuncay S. Short communication: investigation of intestinal coccidia in patients with diarrhea. Mikrobiyol Bul 2007; 41:127-131.
36. Gruz F, Fuxman C, Errea A, et al. Isospora belli infection after isolated intestinal transplant. Transpl Infect Dis 2010; 12:69-72.
37. Lee SC, Corradi N, Doan S, et al. Evolution of the sex-related locus and genomic features shared in microsporidia and fungi. PLoS ONE 2010; 5:e10539.
38. Didier ES, Weiss M. Microsporidiosis: current status. Curr Opin Infect Dis 2006; 19:485-492. (Pubitemid 44338109)
39. Lobo ML, Xiao L, Antunes F, et al. Microsporidia as emerging pathogens and the implication for public health: A 10-year study on HIV-positive and -negative patients. Int J Parasitol 2012; 42:197-205.
40. Suankratay C, Thiansukhon E, Nilarantanakul V, et al. Disseminated infection caused by a novel species of Microsporidium, Thailand. Emerg Infect Dis 2012; 18:302-304.
41. Ghosh K, Weiss LM. T cell response and persistence of the microsporidia. FEMS Microbiol Rev 2012; 36:748-760.
42. Moretto MM, Lawlor EM, Xu Y, et al. Purified PTP1 protein induces antigenspecific protective immunity against Encephalitozoon cuniculi. Microbes Infect 2010; 12:574-579.
43. Heyworth MF. Changing prevalence of human microsporidiosis. Trans R Soc Trop Med Hyg 2012; 106:202-204.
44. Lono A, Kumar S, Chye TT. Detection of microsporidia in local HIV-positive population in Malaysia. Trans R Soc Trop Med Hyg 2011; 105:409-413.
45. Galván AL, Sánchez AM, Valentín MA, et al. First cases of microsporidiosis in transplant recipients in Spain and review of the literature. J Clin Microbiol 2011; 49:1301-1306.
46. Talabani H, Sarfati C, Pillebout E, et al. Disseminated infection with a new genovar of Encephalitozoon cuniculi in a renal transplant recipient. J Clin Microbiol 2010; 48:2651-2653.
47. Yakoob J, Abbas Z, Beg MA, et al. Microsporidial infections due to Encephalitozoon intestinalis in non-HIV-infected patients with chronic diarrhoea. Epidemiol Infect 2011; 1-7.
48. Tu EY, Joslin CE. Microsporidia and Acanthamoeba: the role of emerging corneal pathogens. Eye (Lond) 2012; 26:222-227.
49. Stensvold CR, Lewis HC, Hammerum AM, et al. Blastocystis: unraveling potential risk factors, and clinical significance of a common but neglected parasite. Epidemiol Infect 2009; 137:1655-1663.
50. Batista MV, Pierrotti LC, Abdala E, et al. Endemic and opportunistic infections in Brazilian solid organ transplant recipients. Trop Med Int Health 2011; 16:1134-1142.
51. Stensvold CR, Suresh GK, Tan KS, et al. Terminology for Blastocystis subtypes: a consensus. Trends Parasitol 2007; 23:93.
52. Abdel-Hameed DM, Hassanin OM. Proteaese activity of Blastocystis hominis subtype3 in symptomatic and asymptomatic patients. Parasitol Res 2011; 109:321-327.
53. Puthia MK, Lu J, Tan KS. Blastocystis ratti contains cysteine proteases that mediate interleukin-8 response from human intestinal epithelial cells in an NF-kappaB-dependent manner. Eukaryot Cell 2008; 7:435-443. (Pubitemid 351959671)
54. Chandramathi S, Suresh KG, Mahmood AA, et al. Urinary hyaluronidase activity in rats infected with Blastocystis hominis: evidence for invasion? Parasitol Res 2010; 106:1459-1463.
55. Iguchi A, Yoshikawa H, Yamada M, et al. Expression of interferon gamma and proinflammatory cytokines in the cecal mucosa of rats experimentally infected with Blastocystis sp. strain RN94-9. Parasitol Res 2009; 105:135-140.
56. Santos HJ, Rivera WL. Kinetic analysis of antibody responses to Blastocystis hominis in sera and intestinal secretions of orally infected mice. Parasitol Res 2009; 105:1303-1310.
57. Eida OM, Hussein EM, Eida AM, et al. Evaluation of the nitric oxide activity against Blastocystis hominis in vitro and in vivo. J Egypt Soc Parasitol 2008; 38:521-536.
58. Mirza H, Wu Z, Kidwai F, et al. A metronidazole-resistant isolate of Blastocystis spp. is susceptible to nitric oxide and downregulates intestinal epithelial inducible nitric oxide synthase by a novel parasite survival mechanism. Infect Immun 2011; 79:5019-5026.
59. Coyle CM, Varughese J, Weiss LM, et al. Blastocystis: to treat or not to treat. Clin Infect Dis 2012; 54:105-110.